KAJUPTIN 50M 500

KAJUPTIN 50M 500 (50 mg / 500 mg)

KAJUPTIN 50M 500 is a combination of two antidiabetic medicines: Sitagliptin Phosphate and Metformin Hydrochloride.

This combination is used for the treatment of Type II diabetes mellitus in adults.

INDICATIONS:

Type II diabetes mellitus.

MECHANISM OF ACTION:

Metformin Hydrochloride is an antidiabetic medication (biguanide). It works by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and improving insulin sensitivity.

Sitagliptin Phosphate is a DPP-4 inhibitor that increases insulin release and decreases glucagon secretion, thereby lowering both fasting and post-prandial blood glucose levels.

Together, they help achieve better glycaemic control.

DOSAGE:

1 tablet once or twice daily, depending on the patient?s condition or as directed by the physician.